1. A Model‐Based Approach to Predict Longitudinal HbA1c, Using Early Phase Glucose Data From Type 2 Diabetes Mellitus Patients After Anti‐Diabetic Treatment. (22nd April 2013) Authors: Kjellsson, Maria C.; Cosson, Valérie F.; Mazer, Norman A.; Frey, Nicolas; Karlsson, Mats O. Journal: Journal of clinical pharmacology Issue: Volume 53:Number 6(2013:Jun.) Page Start: 589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bayesian adaptive designs in single ascending dose trials in healthy volunteers. (August 2014) Authors: Guédé, David; Reigner, Bruno; Vandenhende, Francois; Derks, Mike; Beyer, Ulrich; Jordan, Paul; Worth, Eric; Diack, Cheikh; Frey, Nicolas; Peck, Richard Journal: British journal of clinical pharmacology Issue: Volume 78:Number 2(2014:Aug.) Page Start: 393 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. CLRT‐Mod: An efficient methodology for pharmacometric model‐based analysis of longitudinal phase II dose finding studies under model uncertainty. (2nd March 2021) Authors: Buatois, Simon; Ueckert, Sebastian; Frey, Nicolas; Retout, Sylvie; Mentré, France Journal: Statistics in medicine Issue: Volume 40:Number 10(2021) Page Start: 2435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Disease Modeling and Model‐Based Meta‐Analyses to Define a New Direction for a Phase III Program of Gantenerumab in Alzheimer's Disease. Issue 4 (28th February 2022) Authors: Retout, Sylvie; Gieschke, Ronald; Serafin, Daniel; Weber, Cornelia; Frey, Nicolas; Hofmann, Carsten Journal: Clinical pharmacology & therapeutics Issue: Volume 111:Issue 4(2022) Page Start: 857 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and Safety of Peginterferon Alfa‐2a (40KD) in Children With Chronic Hepatitis B: The PEG‐B‐ACTIVE Study. Issue 5 (8th October 2018) Authors: Wirth, Stefan; Zhang, Hongfei; Hardikar, Winita; Schwarz, Kathleen B.; Sokal, Etienne; Yang, Weibo; Fan, Huimin; Morozov, Vyacheslav; Mao, Qing; Deng, Hong; Huang, Yang; Yang, Lei; Frey, Nicolas; Nasmyth‐Miller, Clare; Pavlovic, Vedran; Wat, Cynthia Journal: Hepatology Issue: Volume 68:Issue 5(2018) Page Start: 1681 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Exposure‐Exposure Relationship of Tocilizumab, an Anti–IL‐6 Receptor Monoclonal Antibody, in a Large Population of Patients With Rheumatoid Arthritis. (22nd February 2013) Authors: Levi, Micha; Grange, Susan; Frey, Nicolas Journal: Journal of clinical pharmacology Issue: Volume 53:Number 2(2013:Feb.) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. From waterfall plots to spaghetti plots in early oncology clinical development. (3rd April 2019) Authors: Mercier, Francois; Consalvo, Nicola; Frey, Nicolas; Phipps, Alex; Ribba, Benjamin Journal: Pharmaceutical statistics Issue: Volume 18:Number 5(2019) Page Start: 526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Identification of new oral dosing regimens for the neuraminidase inhibitor oseltamivir in patients with moderate and severe renal impairment. Issue 5 (2nd July 2015) Authors: Kamal, Mohamed A.; Brennan, Barbara J.; Subramoney, Vishak; Lien, Yi Ting (Kayla); Morcos, Peter N.; Frey, Nicolas; Rayner, Craig R. Journal: Clinical pharmacology in drug development Issue: Volume 4:Issue 5(2015:Sep./Oct.) Page Start: 326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Industrial Perspective on the Benefits Realized From the FDA's Model‐Informed Drug Development Paired Meeting Pilot Program. Issue 5 (15th May 2021) Authors: Galluppi, Gerald R.; Brar, Satjit; Caro, Luzelena; Chen, Yuan; Frey, Nicolas; Grimm, Hans Peter; Rudd, Deanne Jackson; Li, Chi‐Chung; Magee, Mindy; Mukherjee, Arnab; Nagao, Lee; Purohit, Vivek S.; Roy, Amit; Salem, Ahmed Hamed; Sinha, Vikram; Suleiman, Ahmed A.; Taskar, Kunal S.; Upreti, Vijay V.... Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 5(2021) Page Start: 1172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Model‐based approach for methoxy polyethylene glycol‐epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease. Issue 4 (21st January 2020) Authors: Chanu, Pascal; Schaefer, Franz; Warady, Bradley A.; Schmitt, Claus Peter; Reigner, Bruno; Schnetzler, Gabriel; Meyer Reigner, Sylvie; Eisner, Mark; Weichert, Arlette; Frey, Nicolas Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 4(2020) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗